ABILIFY 10 mg, tablet 28 tablets, parallel import (MEDIWIN Limited)
Active ingredients: Aripiprazole
Commercialized according to BDPMDispensing in France: Prescription only
Tablet28 tablets, parallel import (MEDIWIN Limited)orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ABILIFY 10 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 28 plaquette(s) thermoformée(s) aluminium de 1 comprimé(s) (distributeur parallèle : MEDIWIN Limited)
- Marketing authorisation holder
- OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Apr 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65198099CIP74950011CIP133400949500116Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARIPIPRAZOLEcomprimé | 10 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.